Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# TED6828: An Open-Label Multi-Dose-Escalation, Safety and Pharmacokinetic Study of SAR3419 Administered as a Single Agent by Intravenous Infusion Every 3 Weeks in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Gordon, Leo I
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
11/20/08
→
11/20/11
Funding
Sanofi US Services Inc.
(TED6828)
View all
View less